IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $126,000 | +334.5% | 21,492 | -3.1% | 0.00% | – |
| Q4 2018 | $29,000 | -62.3% | 22,188 | -0.8% | 0.00% | – |
| Q3 2018 | $77,000 | -23.0% | 22,360 | +1.8% | 0.00% | – |
| Q2 2018 | $100,000 | +47.1% | 21,956 | +7.2% | 0.00% | – |
| Q1 2018 | $68,000 | -19.0% | 20,486 | -5.1% | 0.00% | – |
| Q4 2017 | $84,000 | -28.8% | 21,588 | +88.8% | 0.00% | – |
| Q3 2017 | $118,000 | +14.6% | 11,432 | +8.1% | 0.00% | – |
| Q2 2017 | $103,000 | +114.6% | 10,577 | +51.1% | 0.00% | – |
| Q1 2017 | $48,000 | +37.1% | 6,998 | +8.8% | 0.00% | – |
| Q4 2016 | $35,000 | -99.9% | 6,432 | -0.3% | 0.00% | – |
| Q3 2016 | $48,883,000 | -7.0% | 6,449 | +0.1% | 0.00% | – |
| Q2 2016 | $52,550,000 | -38.9% | 6,440 | -2.8% | 0.00% | – |
| Q1 2016 | $86,000,000 | -35.3% | 6,628 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $133,000,000 | +164097.5% | 6,628 | -0.2% | 0.00% | – |
| Q3 2015 | $81,000 | -99.9% | 6,640 | +0.1% | 0.00% | -100.0% |
| Q2 2015 | $136,971,000 | +69.4% | 6,633 | +73.2% | 0.00% | – |
| Q1 2015 | $80,851,000 | -31.4% | 3,830 | 0.0% | 0.00% | -100.0% |
| Q4 2014 | $117,887,000 | – | 3,830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,962,720 | $16,016,000 | 6.52% |
| Abingworth LLP | 197,300 | $1,610,000 | 1.69% |
| NEXTHERA CAPITAL LP | 85,138 | $695,000 | 0.60% |
| Cormorant Asset Management, LP | 432,990 | $3,533,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 153,000 | $1,248,000 | 0.32% |
| TFS CAPITAL LLC | 102,685 | $838,000 | 0.15% |
| RS INVESTMENT MANAGEMENT CO LLC | 1,227,595 | $10,017,000 | 0.10% |
| Eventide Asset Management | 180,000 | $1,469,000 | 0.09% |
| Focused Wealth Management, Inc | 15,868 | $129,000 | 0.06% |
| Spark Investment Management LLC | 77,500 | $632,000 | 0.06% |